Alfonso G Zulueta

CIK 1596336 · SVP & President, Lilly Int'l · last filed 2025-11-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$72.18M

Companies

5

Total Filings

49

Lifetime Open-Market Net

-$17.62M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CTS Director 35,913 $66.13 $2.37M $99.6K 10 2025-11-10
Calidi Biotherapeutics, Inc. (CLDI.WS) Delisted Director 133,301 $0.01 $773 $0 1 2024-01-04
Syneos Health, Inc. (SYNH) Delisted Director 4,863 $42.98 $209.0K $0 4 2023-09-28
AMRN Director $15.24 $0 2 2022-06-29
LLY SVP & President, Lilly Int'l 61,614 $1133.00 $69.81M -$17.72M 32 2021-02-10

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2017-01-31 LLY Grant (A) +13,150 $991.2K EDGAR
2016-04-28 LLY Sell (S) −12,000 -$915.2K EDGAR
2016-02-02 LLY Sell (S) −5,000 -$393.8K EDGAR
2016-01-28 LLY Grant (A) +7,035 $576.6K EDGAR
2015-11-23 LLY Mixed +2,374 -$133.1K EDGAR
2015-01-30 LLY Grant (A) +11,532 $818.4K EDGAR
2014-11-12 LLY Mixed +2,048 -$103.8K EDGAR
2014-10-03 LLY Mixed +4,949 -$284.3K EDGAR
2014-01-30 LLY Grant (A) +11,333 $614.6K EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.